This issue features a behind-the-scenes look at the ASH annual meeting, bringing newly approved gene therapies to patients, and more.
This issue features a look at hospital ranking systems, the risks and benefits of opioids for pain management, and more.
This special edition features a closer look at immunotherapy, including the challenges and obstacles of clinical trials, the state of CAR T-cell therapy, and immunotherapies in the development pipeline.
This issue features a look at efforts to include individuals with intellectual and developmental disabilities in clinical research, our new "How I Treat In Brief" section, and more.
This issue features a comparison between American and European drug approval processes, a conversation with a lymphoma doctor running for Congress, highlights from recent hematology/oncology meetings, and more.
This bonus issue features conversations with families joined by hematology, highlights from recent hematology/oncology meetings, and more.
This issue features an interview with the FDA's Richard Pazdur, highlights from the 2017 ASCO Annual Meeting, a debate about minimal residual disease in myeloma, and more.
This issue features a look at NIH's new data-sharing requirements, Mikkael Sekeres' thoughts on contract research organizations, and more.
This special edition features updates in the world of myeloid malignancies, including a review of investigational treatment options and news from recent hematologic conferences.
This issue discusses the legacy of Agent Orange and hematologic malignancies, a debate over transplant in myelodysplastic syndromes, and more.